XSNX — NovAccess Global Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $2.10m
Annual balance sheet for NovAccess Global, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.008 | 0 | 0.181 | 0.064 | 0.021 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.198 | 0 | — | — | — |
| Prepaid Expenses | |||||
| Total Current Assets | 0.213 | 0 | 0.208 | 0.125 | 0.062 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.003 | 0 | — | — | — |
| Total Assets | 0.215 | 0 | 0.208 | 0.125 | 0.062 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.29 | 3.45 | 3.97 | 4.78 | 7.86 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.45 | 3.57 | 4.14 | 4.78 | 7.86 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -2.24 | -3.57 | -3.93 | -4.65 | -7.8 |
| Total Liabilities & Shareholders' Equity | 0.215 | 0 | 0.208 | 0.125 | 0.062 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |